VCAM-1 Promotes Angiogenesis of Bone Marrow Mesenchymal Stem Cells Derived from Patients with Trauma-Induced Osteonecrosis of the Femoral Head by Regulating the Apelin/CCN2 Pathway

<div>The characterization of BMSCs: (a) BMSCs were positive for CD73, CD90, and CD105, while negative for CD14, CD19, CD34, CD45, and HLA-DR; (b) morphology of isolated undifferentiated BMSCs; (c) Alcian blue staining for chondrogenic differentiation of BMSCs; (d) Alizarin red S staining for osteogenic differentiation of BMSCs; (e) oil red O staining for lipid differentiation of BMSCs.</div>

Stem Cells International

fig2

Figure 2

Figure 2: VCAM-1 Promotes Angiogenesis of Bone Marrow Mesenchymal Stem Cells Derived from Patients with Trauma-Induced Osteonecrosis of the Femoral Head by Regulating the Apelin/CCN2 Pathway 

Figure 2 | VCAM-1 Promotes Angiogenesis of Bone Marrow Mesenchymal Stem Cells Derived from Patients with Trauma-Induced Osteonecrosis of the Femoral Head by Regulating the Apelin/CCN2 Pathway 